In contrast, we showed in aerobic ERα positive breast cancer cells, that wt p53 conferred resistance to 3-BrPA, since p53 silencing, or use of genetically matched cells with mutant p53 R175H, revealed high susceptibility to 75 μM 3-BrPA [41]. This evidence concerns the gene TP53 and breast carcinoma.